NASDAQ:ADXS - Advaxis, Inc.
$1.07
 $-0.20
-15.75%
12:20PM EDT
2019-07-22
Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors. Axalimogene filolisbac is its lead Lm-LLO immunotherapy product candidate for the treatment of Human Papilloma Virus-associated cancers. ADXS-PSA is its Lm-LLO immunotherapy product candidate that targets the Prostate Specific Antigen (PSA) associated with prostate cancer. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ADXS     avg for
industry  
  avg for
sector  
42 stocks weight:  8. 57   217. 37   399. 45  
42 stocks rank:  3. 88 K 1. 27 K 716. 99  
# analyst opinions:  2. 00   13. 21   13. 71  
mean recommendation:  2. 50   2. 10   2. 04  

quick ratio:  6. 22   5. 49   1. 88  
current ratio:  7. 08   5. 87   2. 36  

target price low:  1. 37   83. 44   114. 90  
target price avg:  0. 97   106. 20   137. 90  
target price high:  1. 50   132. 30   158. 97  
1-yr high:  23. 85   111. 86   142. 57  
last close:  1. 27   86. 79   125. 44  
50-day avg:  2. 40   86. 68   122. 63  
200-day avg:  5. 19   89. 22   121. 38  
1-yr low:  1. 23   69. 78   100. 51  
volume:  204. 93 K 2. 62 M 3. 43 M
50-day avg volume:  275. 46 K 3. 20 M 4. 16 M
200-day avg volume:  419. 68 K 2. 99 M 4. 75 M

1-day return:  3. 25 % -1. 30 % -0. 99 %
this week return:  -18. 85 % 0. 45 % -0. 20 %
12-wk return:  -64. 02 % 0. 94 % 4. 84 %
52-wk return:  -94. 84 % -1. 30 % 10. 55 %

enterprise value (EV):  -23. 52 M 45. 10 B 122. 38 B
market cap:  10. 19 M 38. 96 B 108. 40 B
EBITDA:  -30. 80 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  0. 76   5. 38   11. 93  
enterprise/revenue (EV/R):  -1. 02   57. 92   10. 21  
total revenue:  23. 14 M 9. 91 B 39. 98 B
total debt:  0. 00   10. 90 B 17. 48 B
net income (common):  -29. 18 M 2. 07 B 4. 05 B

shares outstanding:  42. 28 M 538. 09 M 1. 24 B
shares:  5. 41 M 548. 00 M 1. 22 B
shares short:  272. 60 K 10. 98 M 11. 87 M
shares short prior month:  370. 09 K 9. 32 M 12. 05 M
short ratio:  1. 81   5. 60   3. 34  
short % of float:  5. 95 % 6. 48 % 2. 64 %
total cash/share:  4. 20   10. 98   9. 19  
total cash:  33. 71 M 5. 93 B 6. 10 B
free cash flow:  -26. 42 M 2. 92 B 4. 55 B
operating cash flow:  -51. 10 M 3. 80 B 5. 78 B

book value:  5. 38   13. 35   27. 45  
price/book:  0. 24   4. 60   8. 78  
gross profits:  6. 06 M 7. 44 B 36. 13 B
operating margins:  -139. 76 % -308. 40 % -28. 55 %
EBITDA margins:  -133. 14 % 13. 17 % 23. 38 %
profit margins:  -126. 12 % 10. 44 % 14. 18 %
gross margins:  100. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -7. 00   2. 10   4. 23  
forward EPS:  -2. 88   3. 45   7. 10  
P/E:  -0. 18   1. 90   32. 10  
forward P/E:  -0. 44   6. 46   15. 47  
PE/G:  0. 01   0. 70   -0. 54  
growth:  -32. 00 % 265. 63 % 79. 11 %
earnings high:  -1. 24   0. 89   1. 68  
earnings avg:  -1. 32   0. 70   1. 57  
earnings low:  -1. 40   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -31. 35 % -2. 34 % 5. 28 %
return on equity:  -65. 85 % -90. 08 % 133. 53 %
revenue growth:  -32. 00 % 265. 25 % 73. 68 %
revenue/share:  5. 13   12. 72   60. 04  

beta (1yr vs S&P500):  1. 72   1. 27   0. 91  
sharpe (1yr):  -1. 54   0. 16   0. 77  

held % insiders:  3. 65 % 6. 06 % 3. 29 %
held % institutions:  28. 86 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : ADXS
.    101.079 =       101.079 :: --> INITIAL WEIGHT <--
.    - 6.998 =        94.081 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.942 =       182.698 :: P/E factor
.    x 2.209 =       403.572 :: PE/G factor
.    x 1.559 =       629.365 :: beta factor
.    x 0.789 =       496.649 :: sharpe factor
.    x 2.793 =      1387.026 :: current ratio factor
.    x 1.092 =      1514.041 :: quick ratio factor
.    x 1.246 =      1886.477 :: short ratio factor
.    x 1.001 =      1888.702 :: price-to-book factor
.    x 4.488 =      8477.198 :: EBITDA factor
.    x 1.069 =      9058.978 :: EBITDA vs industry factor
.                               --> PERFORMANCE <--
.    x 2.121 =     19212.218 :: sector+industry 1-year gains factor
.    x 1.009 =     19393.352 :: industry 12-weeks return factor
.    x 1.308 =     25364.344 :: industry 2-weeks return factor
.    x 0.947 =     24022.392 :: "drift" penalty 2 days ago
.    x 0.947 =     22751.031 :: "drift" penalty 4 days ago
.    / 2.235 =     10181.279 :: overall "drift" factor
.    x 0.672 =      6841.823 :: largest single-day jump factor
.    x 0.063 =       430.033 :: low price factor
.    x 0.395 =       170.022 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.714 =       121.416 :: forward EPS factor
.    x 0.896 =       108.803 :: forward P/E factor
.    x 1.185 =         128.9 :: industry recommendation factor
.    x 1.831 =       235.967 :: company recommendation factor
.    x 1.003 =       236.619 :: factor historical industry gain for week 29
.    x 8.798 =      2081.672 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         6.755 :: reduced for readability
.    + 1.815 =         8.569 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      8.569 :: FINAL WEIGHT for NASDAQ:ADXS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org